Dicerna Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
DRNA
CUSIP
253031108
All holders as of
Q1 2022
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q1 1 2.00 k $76.0 k
2021 Q4 1 2.00 k $76.0 k
2021 Q3 191 63.3 M $1.28 B
2021 Q2 215 62.0 M $2.32 B
2021 Q1 199 64.0 M $1.63 B
2020 Q4 188 63.8 M $1.41 B
2020 Q3 193 61.1 M $1.11 B
2020 Q2 186 62.6 M $1.59 B
2020 Q1 151 61.7 M $1.14 B
2019 Q4 177 58.5 M $1.29 B
2019 Q3 114 58.2 M $840 M
2019 Q2 105 56.9 M $902 M
2019 Q1 103 59.2 M $872 M
2018 Q4 106 58.8 M $628 M
2018 Q3 101 55.4 M $846 M
2018 Q2 88 46.5 M $570 M
2018 Q1 75 40.9 M $391 M
2017 Q4 52 39.2 M $352 M
2017 Q3 37 11.3 M $65.1 M
2017 Q2 36 11.6 M $36.7 M
2017 Q1 46 11.7 M $39.6 M
2016 Q4 51 11.3 M $32.5 M
2016 Q3 48 12.1 M $71.1 M
2016 Q2 53 12.9 M $47.5 M
2016 Q1 55 15.0 M $80.2 M
2015 Q4 59 15.6 M $185 M
2015 Q3 53 15.7 M $129 M
2015 Q2 67 15.5 M $216 M
2015 Q1 54 13.0 M $313 M
2014 Q4 47 12.4 M $204 M
2014 Q3 42 11.7 M $150 M
2014 Q2 42 12.2 M $275 M
2014 Q1 42 12.4 M $349 M